We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$173M
AUM Growth
+$73.3M
Cap. Flow
+$11.6M
Cap. Flow %
6.67%
Top 10 Hldgs %
96.13%
Holding
83
New
26
Increased
11
Reduced
13
Closed
29

Top Buys

Rank Stock Value
1
VANI icon
Vivani Medical
VANI
+$3.94M
2
FMTO
Femto Technologies Inc. Common Stock
FMTO
+$2.65M
3
ELTK icon
Eltek
ELTK
+$1.68M
4
RDHL
Redhill Biopharma
RDHL
+$1.65M
5
GMM icon
Global Mofy Metaverse
GMM
+$1.57M

Top Sells

Rank Stock Value
1
MMAT
Meta Materials Inc. Common Stock
MMAT
+$904K
2
PHUN icon
Phunware
PHUN
+$821K
3
CYN icon
Cyngn
CYN
+$507K
4
TGL icon
Treasure Global
TGL
+$426K
5
DUO
Fangdd Network Group
DUO
+$392K

Sector Composition

Rank Sector Weight
1 Healthcare 5.65%
2 Technology 1.24%
3 Materials 0.46%
4 Industrials 0.37%
5 Energy 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$60.4M 34.83%
1,154
+200
+21% +$99.6K
OEF icon
2
PUT
iShares S&P 100 ETF
OEF
$19.8B
$54.2M 31.27%
2,577
+500
+24% +$118K
SPY icon
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$26.2M 15.09%
+500
New +$249K
OEF icon
4
CALL
iShares S&P 100 ETF
OEF
$19.8B
$15.8M 9.1%
+750
New +$177K
VANI icon
5
Vivani Medical
VANI
$113M
$4.95M 2.85%
+2,673,018
New +$3.94M
ELTK icon
6
Eltek
ELTK
$57.7M
$1.26M 0.73%
+113,000
New +$1.68M
RDHL
7
Redhill Biopharma
RDHL
$4.44M
$1.23M 0.71%
+92,770
New +$1.65M
TNXP icon
8
Tonix Pharmaceuticals
TNXP
$158M
$911K 0.53%
1,530
+563
+58% +$606K
GMM icon
9
Global Mofy Metaverse
GMM
$4.82M
$528K 0.3%
+855
New +$1.57M
CHNR icon
10
China Natural Resources
CHNR
$4.54M
$511K 0.29%
+53,649
New +$538K
CKPT
11
PUT
DELISTED
Checkpoint Therapeutics
CKPT
$486K 0.28%
2,373
+1,421
+149% +$2.83K
BTBT icon
12
PUT
Bit Digital
BTBT
$459M
$469K 0.27%
1,634
+420
+35% +$1.16K
RCON icon
13
Recon Technology
RCON
$39.6M
$420K 0.24%
157,811
-33,836
-18% -$108K
BIVI icon
14
BioVie
BIVI
$10M
$364K 0.21%
+6,891
New +$706K
NEXI
15
DELISTED
NexImmune, Inc. Common Stock
NEXI
$336K 0.19%
+59,851
New +$461K
AUVI
16
DELISTED
Applied UV, Inc. Common Stock
AUVI
$323K 0.19%
+217,084
New +$460K
GLBS icon
17
PUT
Globus Maritime Ltd
GLBS
$60.9M
$320K 0.18%
1,456
+264
+22% +$601
SIDU icon
18
Sidus Space
SIDU
$172M
$282K 0.16%
+83,100
New +$518K
GEVO icon
19
Gevo
GEVO
$363M
$269K 0.16%
350,000
-13,029
-4% -$11.3K
BRTX icon
20
BioRestorative Therapies
BRTX
$6.79M
$233K 0.13%
+168,544
New +$260K
SUNE
21
SUNation Energy
SUNE
$8.86M
$231K 0.13%
+23
New +$860K
RNAZ icon
22
TransCode Therapeutics
RNAZ
$4.75M
$229K 0.13%
+362
New +$506K
GCTK icon
23
GlucoTrack
GCTK
$1.97M
$204K 0.12%
102
+31
+44% +$48.6K
ENSC icon
24
Ensysce Biosciences
ENSC
$3.86M
$182K 0.11%
+15,370
New +$244K
LIPO
25
DELISTED
Lipella Pharmaceuticals
LIPO
$171K 0.1%
31,237
-2,492
-7% -$18.5K
1
2 3 4

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2024 Portfolio in Review

As of Q1 2024, Sabby Management held 83 positions worth $173M, up 73% from $100M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Sabby Management deployed $11.6M of net new capital in Q1 2024, opening 26 new positions and adding to 11 existing holdings. Its largest new stake was Vivani Medical: 2,673,018 shares worth $4.95M.

By sector, the portfolio is most concentrated in Healthcare at 5.6% of assets, up from 3.8% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Akari Therapeutics, an estimated $279K trimmed.

  • Sabby Management's largest Q1 2024 buy was Vivani Medical: 2,673,018 shares worth $4.95M.
  • Sabby Management added most to Femto Technologies Inc. Common Stock in Q1 2024, an estimated $2.65M increase.
  • Sabby Management's biggest Q1 2024 reduction was Akari Therapeutics, cutting an estimated $279K.
  • Sabby Management fully exited Meta Materials Inc. Common Stock in Q1 2024, selling an estimated $904K.
  • Sabby Management's ten largest holdings make up 96% of its $173M portfolio in Q1 2024.
  • Sabby Management opened 26 new positions and closed 29 in Q1 2024.
  • Sabby Management's portfolio value rose 73% quarter-over-quarter to $173M.

Based on Sabby Management's 13F filing for Q1 2024, filed 15 May 2024.